Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects

Inclusion Criteria: * Body Mass Index (BMI) between 18.5 and 30 kg/m2 * Good general health based on assessment of medical history, physical examination, ECG (electrocardiogram), and clinical laboratory data at screening, as judged by the physician * Non-smokers Exclusion Criteria: * Known history of thromboembolic event(s) or potential thromboembolic risk as judged by the physician * Blood transfusion within 3 months of trial start * Positive for hepatitis B or C infection * Positive for Human Immunodeficiency Virus (HIV) infection * Excessive consumption of a diet deviating from a normal diet as judged by the physician * Blood or plasma donation within the last 3 months prior to trial start * Subjects with any history of migraine